Leaderboard

En | De
Sie sind hier: Neurologie » Parkinson 28. September 2026
Suchen
medline.ch
Parkinson
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Alzheimer
Epilepsie
Infektionen
Kopfschmerzen
Multiple Sklerose
Neoplasie
Neuromuskuläre Erkrankungen
Parkinson
Zerebrovaskuläre Erkrankungen
ZNS Trauma
Anderes
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2951  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 59001  
   
The patient-centric development of an inclusive multi-arm multi-stage trial for Parkinson's disease.
Brain Commun
Zeissler ML, Burnell M, Barber TR, Ben-Shlomo Y, Clarke CS, Collins S, Counsell C, Duffen J, Edwards MJ, Ellis-Doyle R, Gonzalez-Robles C, Hockey K, Jewell A, Lawton M, Mills G, Petty R, Salathiel D, Whipps S, Whone A, Gandhi S, Carroll CB, Foltynie T, Carpenter JR, Barker RA, EJS ACT-PD Consortium, EJS ACT-PD Consortium.
PMID: 42802821 [PubMed]


Mendelian randomization analysis reveals causal links between specific immune cell phenotypes and Parkinson's disease.
Clinics (Sao Paulo)
Su Y, Cai S, Xu Y, Xu Q, Wang Q, Chen X.
PMID: 42801837 [PubMed - as supplied by publisher]


Comparative study of Parkinson's disease phenotypes in homozygous and heterozygous LRRK2-G2019S mutation carriers.
Acta Neurol Belg
Abida Y, Sghaier I, Gharbi A, Souissi A, Elloumi M, Atrous A, Gargouri A, Kacem I, Gouider R.
PMID: 42801451 [PubMed - as supplied by publisher]


Ambroxol in Gaucher disease and GBA1-related Parkinson disease: an updated systematic review.
Acta Neurol Belg
Lipi, Jezela-Stanek A, Tylki-Szyma.
PMID: 42801449 [PubMed - as supplied by publisher]


White matter fractional anisotropy predicts Parkinson's disease medication changes with deep brain stimulation.
Parkinsonism Relat Disord
Schoen D, Shih P, West L, Deutsch S, Mehta J, Williams C, Wang S, Wang DD, Ostrem JL, Bledsoe IO, Morrison MA.
PMID: 42800200 [PubMed - as supplied by publisher]


Symptomatic Rescue or Disease Modification? A Critical Review of Levodopa and Phytochemical Interventions in Caenorhabditis elegans Models of Parkinson's Disease.
Mol Neurobiol
Akta, Berk .
PMID: 42799932 [PubMed - indexed for MEDLINE]


Systemic AR-C155858 During Fixed Treadmill Exercise in MPTP Mice: An Exploratory Study.
Neurochem Res
Kong J, Liu L, Zhao G, Gao Y, Yang Z, Zeng R, Tan M, Wang H, Liu Y, Chen W.
PMID: 42799796 [PubMed - indexed for MEDLINE]


Tremor relief after gamma knife thalamotomy for Parkinson's disease.
Neurosurg Rev
Reyes JS, Bouras A, Hadjipanayis CG, Lunsford LD, Niranjan A.
PMID: 42799781 [PubMed - indexed for MEDLINE]


Neuroinflammation and metabolic reprogramming in Parkinson's disease.
Front Immunol
Fu Y, Yu J, Xu L, Zhou T, Deng Q.
PMID: 42798987 [PubMed - indexed for MEDLINE]


MAFF as a potential novel protective factor against Parkinson's disease: evidence from Mendelian randomization and single-cell RNA sequencing.
Front Aging Neurosci
Li X, Wang Q, Min G, Yuan X, Tian Y.
PMID: 42798606 [PubMed]


Beyond bacteria: a multi-omics view of the gut-brain axis in Parkinson's disease.
Front Cell Infect Microbiol
Han H, Luo O, Li K, Rahaman S, Ok EU, Zhang L, Liang M, Lin H.
PMID: 42798356 [PubMed - indexed for MEDLINE]


Image-guided programming improves motor control in chronic subthalamic nucleus deep brain stimulation in Parkinson's disease: A prospective study.
J Parkinsons Dis
Lee JS, Ha J, Kim S, Cho JW, Lee JI, Youn J.
PMID: 42798288 [PubMed - as supplied by publisher]


A review of FDG-PET biomarker analysis methods in Parkinson's disease.
J Parkinsons Dis
Reimers E, Bevington C, Stoessl AJ, Sossi V.
PMID: 42798283 [PubMed - as supplied by publisher]


Exploratory SWI-based texture analysis of the substantia nigra on MRI in parkinson's disease.
Medicine (Baltimore)
Tavut D, Baykara M, Yildirim H.
PMID: 42798098 [PubMed - indexed for MEDLINE]


Nose-to-Brain Therapeutics in Parkinson's Disease: Clinical Trials, Mechanisms, and Therapeutic Potential.
Pharmaceutics
Cherny E, Minko T.
PMID: 42797274 [PubMed]


Andrographolide: Mechanisms and Therapeutic Potential in Alzheimer's and Parkinson's Disease.
Molecules
Ríos-Gallardo A, Herrera-Ramirez D, Bastias-Candia S, Inestrosa NC.
PMID: 42796428 [PubMed - indexed for MEDLINE]


Long-Term Clinical Efficacy, Safety, and Polypharmacy Simplification of Levodopa-Entacapone-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: An 18-Month Longitudinal Study.
J Clin Med
Orbán-Kis K, Szatmári S, Constantin VA, Szász RM, B, Szederjesi J, Ciorba M, Nagy EE, Neagoe RM, Kelemen K, Bíró K, Ciorba Nicoleta C, Mihály I, Frigy A, Szász JA.
PMID: 42796091 [PubMed]


Serum Granzyme B in Parkinson's Disease: A Case-Control Study of Diagnostic Association.
J Clin Med
Almulhim MF, Elgamal S, Ghazy AA, Saleh SA, Eissa SA, Shatara SA, Shatara YA, Rashwan EK, Ismail MA.
PMID: 42795888 [PubMed]


Mechanisms of Brain Aging and Their Links to Alzheimer's and Parkinson's Disease Pathology.
Int J Mol Sci
Yi H, Qin H, Goon JA, Makpol S, Tan JK.
PMID: 42794852 [PubMed - indexed for MEDLINE]


Bioactivated Glucoraphanin Exerts a Potential Protective Effect in an In Vitro Model of Parkinson's Disease: A Transcriptomic Study.
Int J Mol Sci
Gugliandolo A, Muscarà C, Floramo A, Argento V, Tagliavento L, Meneguzzo F, Perenzoni D, Mattivi F, Mazzon E, Chiricosta L.
PMID: 42794660 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 59001    Seite 1 von 2951  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1